| Literature DB >> 24501242 |
Miklos Perenyei1, David R W Jayne1, Oliver Floßmann2.
Abstract
Gusperimus is an immunosuppressive drug with a unique mode of action. We review its effects on different arms of the immune system and the current evidence for clinical applications, particularly in the treatment of transplant rejection and ANCA-associated vasculitis.Entities:
Keywords: deoxyspergualin; glomerulonephritis; gusperimus; immune suppressant; rejection; systemic lupus erythematosus; transplantation; vasculitis
Mesh:
Substances:
Year: 2014 PMID: 24501242 DOI: 10.1093/rheumatology/ket451
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580